Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TBDx Feasibility Study: Prospective Study to Determine the Feasibility of Automated Smear Microscopy

NCT02912832 is registered in ClinicalTrials.gov with Foundation for Innovative New Diagnostics, Switzerland as lead sponsor.

NCT NCT02912832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02912832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TBDx Feasibility Study: Prospective Study to Determine the Feasibility of Automated Smear Microscopy
Lead sponsor
Foundation for Innovative New Diagnostics, Switzerland
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2014
Completion date
August 31, 2015
Enrollment
572 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary tuberculosis